CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -5.9% | 11,604 | +20.8% | 0.00% | -50.0% |
| Q2 2022 | $17,000 | -74.6% | 9,604 | -62.0% | 0.00% | -66.7% |
| Q1 2022 | $67,000 | -38.0% | 25,304 | +0.6% | 0.01% | -33.3% |
| Q4 2021 | $108,000 | +145.5% | 25,154 | +269.9% | 0.01% | +80.0% |
| Q4 2020 | $44,000 | +109.5% | 6,800 | +161.5% | 0.01% | +66.7% |
| Q2 2020 | $21,000 | -46.2% | 2,600 | -51.9% | 0.00% | -25.0% |
| Q3 2019 | $39,000 | -47.3% | 5,400 | +33.5% | 0.00% | -20.0% |
| Q3 2018 | $74,000 | +34.5% | 4,046 | +65.9% | 0.01% | +25.0% |
| Q2 2018 | $55,000 | -15.4% | 2,439 | -21.7% | 0.00% | -33.3% |
| Q4 2017 | $65,000 | – | 3,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |